World-first study to explore psilocybin for gambling addiction
Marking a world first, researchers at Imperial’s Centre for Psychedelic Research will investigate psilocybin as a treatment for gambling addiction with the support of funding from the UK Research and Innovation (UKRI) fund.
The Centre will be carrying out a small study involving five volunteers with gambling addiction to test if psychedelic therapy is safe and could have therapeutic potential.
From October 2023, the volunteers will be given psilocybin in combination with talking therapy and will undergo brain imaging to monitor patterns of brain activity and connectivity using functional magnetic resonance imaging (fMRI) and electroencephalography (EEG).
The study is being led by leading researchers in the field, including Professor David Nutt, Dr David Erritzoe, Dr Matt Wall and Rayyan Zafar, PhD, from Imperial College Centre for Psychedelic Research and Neuropsychopharmacology.READ MORE